Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Travere Therapeutics granted 32,000 restricted stock units to six new employees as inducements to employment. The grants were approved by the Compensation Committee on June 10, 2026, and vest over four years with 25% vesting annually.
Key figures
- New employees
- 6
- Shares granted
- 32000
- Vesting period years
- 4
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.